First-line management common to all severities of eczema includes the use of short-term topical corticosteroids to control flare ups, combined with the long-term use of moisturisers or emollients to relieve symptoms and maintain the skin barrier. [1]
Research has shown that together, we can achieve up to 4 x better clinical outcomes when topical corticosteroids and emollients are used in combination to manage eczema. By adding an emollient to active treatment, eczema severity is reduced and may led to fewer flares. [2]
With Ego’s extensive history since 1953 and portfolio of topical corticosteroids and emollients, our mission is to improve consumers’ skin quality and work towards delivering better long-term clinical outcomes for your eczema patients.
1.
2.